维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Hasenclever"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Does Religion Make a Difference? Theoretical Approaches to the Impact of Faith on Political Conflict显示文摘	Hasenclever Andreas Rittberger Volker		0，，：	1
2	Role of urokinasetype plasminogen activator (uPA)and plasminogen activator inhibitor type1 (PAI-1)for prognosis in endometrial cancer显示文摘	Steiner E Pollow K Hasenclever D	2008	Gynecol Oncol2008，108，：	1
3	Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer显示文摘	Steiner E Pollow K Hasenclever D	2008	Gynecol Oncol2008，108，3：	1
4	A prognostic score for advanced Hodgkin's disease 显示文摘	Hasenclever D Diehl V	1998	N Engl J Med1998，339，21：	1
5	BEACOPP, a new dose -escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced- stage Hodgkin's lympho- ma: interim report from atrial of the German Hodgkin's Lymphoma Study Group显示文摘	DIEHL V FRANKLIN J HASENCLEVER D	1998	J Clin Oncol1998，16，12：	1
6	Safety of AlloPBPCT donors: biomet- rical considerations on monitoring long term risks 显示文摘	Hasenclever D Sextro M	1996	Bone Marrow Transplant1996，2，：	1
7	StandardInternational Prognostic Index remains a valid predictor ofoutcome for patients with aggressive CD20 - B-celllymphoma in the rituximab era 显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin Oncol2010，28，14：	1
8	A prognostic score for advanced Hodgkin~ disease显示文摘	Hasenclever D Diehl V Armitage JO	1998	New Eng J Med1998，339，21：	1
9	Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 ( PAI-1 ) for prognosis in endometrial cancer 显示文摘	Steiner E Pollow K Hasenclever D	2008	Gynecol 0ncol2008，108，3：	1
10	Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial显示文摘	Birte Friedrichs André Tichelli Andrea Bacigalupo Nigel H Russell Tapani Ruutu Michael Y Shapira Meral Beksac Dirk Hasenclever Gérard Socié Norbert Schmitz	2010	Lancet Oncology2010，，4：	1
11	Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation 显示文摘	Schmitz N Bacigalupo A Hasenclever D	1998	Bone Marrow Transplant1998，21，10：	1
12	Role of the progesterone receptor for paclitaxel resistance in primary breast cancer显示文摘	Schmidt M Bremer E Hasenclever D	2007	Br J Cancer2007，96，2：	1
13	Role of the progesterone receptor for paclitaxel resistance in primary breast cancer显示文摘	SCHMIDT M BREMER E HASENCLEVER D	2007	Br J Cancer2007，96，2：	1
14	ErbB 3 predicts survival in ovarian cancer显示文摘	Tanner B Hasenclever D Stern K	2006	J Clin Oncol2006，24，：	1
15	The disappearance of prognostic factors in Hodgkin' s disease显示文摘	HASENCLEVER D	2002	Ann Oncol2002，13，1：	1
16	Standard International prognostic index remains a valid predictor of outcome for patients with aggressiveCD20+B-cell lymphoma in the rituximab era显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin Oncol2010，28，14：	1
17	Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+B-cell lymphoma in the rituximab era显示文摘	Ziepert M Hasenclever D Kuhnt E	2010	J Clin Oncol2010，28，：	1
18	Thoraco-abdom- inal high-pitch dual-source CT angiography:experimental evalua tion of injection protocols with an alaatomical human vascular phantom显示文摘	Puippe GD Winklehner A Hasenclever P	2012	Eur J Radiol2012，81，10：	1
19	Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia:first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation显示文摘	Schmitz N Bacigalupo A Hasenclever D	1998	Bone Marrow Transplant1998，21，10：	1
20	ErbB-3 pre-dicts survival in ovarian cancer显示文摘	Tanner B Hasenclever D Stern K	2006	J Clin Oncol2006，24，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示